These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17188523)

  • 21. Effects of proteasome inhibitors on cytokines, metalloproteinases and their inhibitors and collagen type-I expression in periprosthetic tissues and fibroblasts from loose arthroplasty endoprostheses.
    Niarakis A; Giannopoulou E; Syggelos SA; Panagiotopoulos E
    Connect Tissue Res; 2019 Nov; 60(6):555-570. PubMed ID: 30931650
    [No Abstract]   [Full Text] [Related]  

  • 22. Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: up-regulation of TNF, IFN-gamma and IL-2, in contrast to down-regulation of IL-6 production.
    Tsuboi I; Tanaka H; Nakao M; Shichijo S; Itoh K
    Cytokine; 1995 May; 7(4):372-9. PubMed ID: 8589268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis.
    Alvarez-Soria MA; Herrero-Beaumont G; Moreno-Rubio J; Calvo E; Santillana J; Egido J; Largo R
    Osteoarthritis Cartilage; 2008 Dec; 16(12):1484-93. PubMed ID: 18547825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro.
    Berg J; Fellier H; Christoph T; Grarup J; Stimmeder D
    Inflamm Res; 1999 Jul; 48(7):369-79. PubMed ID: 10450786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses.
    Syggelos SA; Eleftheriou SC; Giannopoulou E; Panagiotopoulos E; Aletras AJ
    J Rheumatol; 2001 Jun; 28(6):1319-29. PubMed ID: 11409126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of human articular chondrocytes cultured in alginate beads. Longterm effects of interleukin 1beta and nonsteroidal antiinflammatory drugs.
    Sanchez C; Mateus MM; Defresne MP; Crielaard JM; Reginster JY; Henrotin YE
    J Rheumatol; 2002 Apr; 29(4):772-82. PubMed ID: 11950021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial.
    Gallelli L; Galasso O; Falcone D; Southworth S; Greco M; Ventura V; Romualdi P; Corigliano A; Terracciano R; Savino R; Gulletta E; Gasparini G; De Sarro G
    Osteoarthritis Cartilage; 2013 Sep; 21(9):1400-8. PubMed ID: 23973155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The membrane-type-matrix metalloproteinase/matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 system in periprosthetic connective-tissue remodeling in loose total-hip prostheses.
    Takagi M; Santavirta S; Ida H; Ishii M; Akimoto K; Saotome K; Konttinen YT
    Lab Invest; 1998 Jun; 78(6):735-42. PubMed ID: 9645764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a novel non-steroidal anti-inflammatory drug (M-5011) on cytokine levels in rats with monosodium urate crystal- induced pleurisy.
    Murakami N; Aihara S; Iwata K; Saito T; Naruse T
    Jpn J Pharmacol; 1999 Apr; 79(4):439-46. PubMed ID: 10361883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue inhibitor of metalloproteinase 1, collagenolytic and gelatinolytic activity in loose hip endoprostheses.
    Takagi M; Konttinen YT; Kemppinen P; Sorsa T; Tschesche H; Bläser J; Suda A; Santavirta S
    J Rheumatol; 1995 Dec; 22(12):2285-90. PubMed ID: 8835563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of a latent soluble form of membrane type 1 matrix metalloprotease bound with tissue inhibitor of matrix metalloproteinases-2 in periprosthetic tissues and fluids from loose arthroplasty endoprostheses.
    Niarakis A; Giannopoulou E; Ravazoula P; Panagiotopoulos E; Zarkadis IK; Aletras AJ
    FEBS J; 2013 Dec; 280(24):6541-55. PubMed ID: 24112707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of 18F-FDG-PET in the diagnosis of endoprosthetic loosening of knee and hip implants.
    Mayer-Wagner S; Mayer W; Maegerlein S; Linke R; Jansson V; Müller PE
    Arch Orthop Trauma Surg; 2010 Oct; 130(10):1231-8. PubMed ID: 19890653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration.
    Tziakas DN; Chalikias GK; Parissis JT; Hatzinikolaou EI; Papadopoulos ED; Tripsiannis GA; Papadopoulou EG; Tentes IK; Karas SM; Chatseras DI
    Int J Cardiol; 2004 Apr; 94(2-3):269-77. PubMed ID: 15093992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci.
    LeGrand A; Fermor B; Fink C; Pisetsky DS; Weinberg JB; Vail TP; Guilak F
    Arthritis Rheum; 2001 Sep; 44(9):2078-83. PubMed ID: 11592370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of human osteoblasts and macrophages to bone matrix degradation and proinflammatory cytokine release after exposure to abrasive endoprosthetic wear particles.
    Jonitz-Heincke A; Lochner K; Schulze C; Pohle D; Pustlauk W; Hansmann D; Bader R
    Mol Med Rep; 2016 Aug; 14(2):1491-500. PubMed ID: 27357630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
    Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
    Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyethylene wear particles do not induce inflammation or gelatinase (MMP-2 and MMP-9) activity in fibrous tissue interfaces of loosening total hip arthroplasties.
    De Jong PT; Tigchelaar W; Van Noorden CJ; Van der Vis HM
    Acta Histochem; 2011 Sep; 113(5):556-63. PubMed ID: 20656340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic enhancement of cytokine-induced human monocyte matrix metalloproteinase-1 by C-reactive protein and oxidized LDL through differential regulation of monocyte chemotactic protein-1 and prostaglandin E2.
    Zhang Y; Wahl LM
    J Leukoc Biol; 2006 Jan; 79(1):105-13. PubMed ID: 16244112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells.
    Uchida M; Shima M; Shimoaka T; Fujieda A; Obara K; Suzuki H; Nagai Y; Ikeda T; Yamato H; Kawaguchi H
    J Cell Physiol; 2000 Nov; 185(2):207-14. PubMed ID: 11025442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Degenerative changes of the interface membrane as a possible reason for prosthesis loosening.
    Krohmer G; Koleganova N; Hadjicostas PT; Fink B; Berger I
    Histol Histopathol; 2008 Aug; 23(8):925-33. PubMed ID: 18498067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.